Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Equillium, Inc. logo

Equillium, Inc. (EQ) Stock Ticker

NASDAQ: EQ · Healthcare · Biotechnology
$1.67-2.91%
USD · as of 2026-09-27 · market cap $105.6M
Open EQ in TickrDownload for iPhone

EQ right now

31% of the float is sold short.
Options expect by Oct 6±18.7%
Options expect by Oct 29±38.7%
Priced in for Nov 12 earnings±46.8%
IV rank (30-day)36% · fair
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full EQ picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on EQ
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Equillium, Inc.

Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune checkpoint receptor. Itolizumab is currently in Phase III trials for acute graft-versus-host disease, has completed Phase Ib studies for asthma, and is also undergoing Phase Ib trials for lupus nephritis. In addition to itolizumab, Equillium is advancing EQ101 for the treatment of cutaneous T cell lymphoma and alopecia areata, and EQ102, which targets various gastrointestinal conditions. Headquartered in La Jolla, California, the company was incorporated in 2017 and previously operated as Attenuate Biopharmaceuticals, Inc. before changing its name to Equillium, Inc. in May 2017.

EQ stock facts

Ticker symbolEQ
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$105.6M
CEOBruce D. Steel
Employees14
HeadquartersLa Jolla, CA, US
IPO date2018-10-12
Websiteequilliumbio.com

What you can see for EQ on Tickr

Live EQ price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the EQ report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Equillium, Inc.?

The ticker symbol for Equillium, Inc. is EQ, listed on the NASDAQ Global Market.

What is EQ?

Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune…

HomeExploreMarketLists
All pages